Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review

被引:0
|
作者
Fatemeh Yarmohammadi
A. Wallace Hayes
Gholamreza Karimi
机构
[1] Mashhad University of Medical Sciences,Student Research Committee
[2] Mashhad University of Medical Sciences,Department of Pharmacodynamics and Toxicology, School of Pharmacy
[3] University of South Florida,Center for Environmental Occupational Risk Analysis and Management, College of Public Health
[4] Mashhad University of Medical Sciences,Pharmaceutical Research Center, Pharmaceutical Technology Institute
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2021年 / 394卷
关键词
Mitochondrial dysfunction; Herat injury; Oxidative stress; Inflammation; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiotoxicity is a major adverse effect that can be induced by both therapeutic agents and industrial chemicals. The pathogenesis of such cardiac damage is multifactorial, often injuring the cardiac tissue by generating free radicals, oxidative stress, and/or inflammation. Curcumin (CUR) is a bright yellow chemical produced by Curcuma longa plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. Administration of CUR has been reported to ameliorate the chemical and drug-induced cardiac injury in several studies. CUR has been suggested to act as an effective candidate against oxidative stress and inflammation in heart tissue via regulation of Nrf2 and suppression of p38 MAPK/NF-κB and NLRP3 inflammasomes. The anti-apoptotic properties of CUR have also been reported to modulate the AMPK, Akt, JNK, and ERK signaling pathways. This review explores the potential protective effects of CUR regarding the detrimental effects often observed in cardiac tissue following exposure to several chemicals including drugs.
引用
收藏
页码:1341 / 1353
页数:12
相关论文
共 50 条
  • [21] Characterising the mechanisms of drug-induced structural cardiotoxicity
    Burke, Niall
    Pilling, James
    Pointon, Amy
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 123 - 123
  • [22] Literature review of the evidence regarding intravenous lipid administration in drug-induced cardiotoxicity
    Paneta, Maria
    Waring, William Stephen
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (07) : 591 - 602
  • [23] Role of non-cardiomyocytes in anticancer drug-induced cardiotoxicity: A systematic review
    Xie, Suifen
    Yang, Yuanying
    Luo, Ziheng
    Li, Xiangyun
    Liu, Jian
    Zhang, Bikui
    Li, Wenqun
    ISCIENCE, 2022, 25 (11)
  • [24] The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity
    Liu, Xuening
    Li, Zijian
    BASIC RESEARCH IN CARDIOLOGY, 2025, 120 (01) : 11 - 24
  • [25] Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
    Li, Mo-Yun
    Peng, Li-Ming
    Chen, Xiao-Ping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [26] A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity
    Obiol-Pardo, Cristian
    Gomis-Tena, Julio
    Sanz, Ferran
    Saiz, Javier
    Pastor, Manuel
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (02) : 483 - 492
  • [27] Drug-induced cardiotoxicity assessment by cell motion imaging
    Satsuka, Ayano
    Hayashi, Sayo
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [28] Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
    Ma, Wanjun
    Wei, Shanshan
    Zhang, Bikui
    Li, Wenqun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [29] Cilastatin as a protective agent against drug-induced nephrotoxicity: a literature review
    Shayan, Mersedeh
    Elyasi, Sepideh
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 999 - 1009
  • [30] Development of an in vitro platform for the study of drug-induced cardiotoxicity
    Anene-Nzelu, G. C.
    Choudhury, D.
    Liang, L. Hwa
    Yu, H.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 348 - 348